| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 673038 | 61462 | FENIVIR 10 mg/g CREMA | FENIVIR 10 mg/g CREMA, 1 tubo de 2 g | 10 mg/g | 44 | 2 | 21 | 1 tubo de 2 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61462/61462_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61462/61462_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28863 | PERRIGO ESPANA S.A. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2011-10-28 | View Edit Delete | ||||||||||||
| 672088 | 19495 | OFTALMOLOSA CUSI CLORAMFENICOL 10 MG/G POMADA OFTÁLMICA | OFTALMOLOSA CUSI CLORAMFENICOL 10 MG/G POMADA OFTÁLMICA 1 tubo de 3 g | 10 mg/g | 44 | 3 | 21 | 1 tubo de 3 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/19495/19495_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/19495/19495_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23570 | OMNIVISION FARMA ESPANA S.L. | 1953-07-01 | 1 | 1 | 1 | 1953-07-01 | 2011-04-11 | 0 | 2011-10-17 | 797613, 653110, 656651, 656831 | View Edit Delete | |||||||||||
| 672694 | 47396 | PENILEVEL RETARD 1.000.000 U.I. | PENILEVEL RETARD 1.000.000 U.I. , 1 vial + 1 ampolla de disolvente | 200.000 UI/600.000 UI/200.000 UI | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1969-03-01 | 1 | 1 | 1 | 1969-03-01 | 2011-03-29 | 0 | 2011-09-21 | 819177, 653435 | View Edit Delete | |||||||||||
| 672084 | 33411 | GENOXAL 200 mg POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN | GENOXAL 200 mg POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN , 1 vial | 200 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/33411/33411_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/33411/33411_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7980 | BAXTER S.L. | 1960-02-01 | 1 | 1 | 1 | 1960-02-01 | 2011-03-10 | 0 | 2011-07-01 | 876383, 663200 | View Edit Delete | |||||||||||
| 674127 | 96011001 | CAELYX PEGYLATED LIPOSOMAL 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | CAELYX PEGYLATED LIPOSOMAL 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 2 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/96011001/96011001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/96011001/96011001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30180 | BAXTER S.L. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 673954 | 63535 | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL , 1 vial de 15 ml | 1 mmol/ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63535/63535_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63535/63535_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11424 | BAYER HISPANIA S.L. | 2001-01-16 | 1 | 1 | 1 | 2001-01-16 | 2001-01-16 | 0 | 2011-10-11 | View Edit Delete | ||||||||||||
| 674119 | 63535 | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL , 1 vial de 30 ml | 1 mmol/ml | 45 | 1 | 34 | 1 vial de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63535/63535_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63535/63535_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11424 | BAYER HISPANIA S.L. | 2001-01-16 | 1 | 1 | 1 | 2001-01-16 | 2001-01-16 | 0 | 2011-10-11 | View Edit Delete | ||||||||||||
| 672784 | 73023 | REMIFENTANILO KERN PHARMA 1 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | REMIFENTANILO KERN PHARMA 1 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG , 5 viales | 1 mg | 45 | 5 | 34 | 5 viales | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73023/73023_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73023/73023_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2010-11-17 | 1 | 1 | 1 | 2010-11-17 | 2010-11-17 | 0 | 2011-03-14 | Lista I | View Edit Delete | |||||||||||
| 672785 | 73025 | REMIFENTANILO KERN PHARMA 5 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | REMIFENTANILO KERN PHARMA 5 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG , 5 viales | 5 mg | 45 | 5 | 34 | 5 viales | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73025/73025_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73025/73025_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2010-11-17 | 1 | 1 | 1 | 2010-11-17 | 2010-11-17 | 0 | 2011-03-14 | Lista I | View Edit Delete | |||||||||||
| 672786 | 73024 | REMIFENTANILO KERN PHARMA 2 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | REMIFENTANILO KERN PHARMA 2 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG , 5 viales | 2 mg | 45 | 5 | 34 | 5 viales | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73024/73024_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73024/73024_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2010-11-17 | 1 | 1 | 1 | 2010-11-17 | 2010-11-17 | 0 | 2011-03-14 | Lista I | View Edit Delete | |||||||||||
| 672521 | 70886 | IRINOTECAN KABI 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | IRINOTECAN KABI 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 15 ml | 20 mg/ml inyectable 15 ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70886/70886_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70886/70886_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2009-05-04 | 1 | 1 | 1 | 2009-05-04 | 2010-08-30 | 1 | 2019-01-31 | View Edit Delete | ||||||||||||
| 672522 | 70886 | IRINOTECAN KABI 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | IRINOTECAN KABI 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 25 ml | 20 mg/ml inyectable 25 ml | 45 | 1 | 34 | 1 vial de 25 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70886/70886_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70886/70886_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2009-05-04 | 1 | 1 | 1 | 2009-05-04 | 2010-08-30 | 1 | 2019-01-31 | View Edit Delete | ||||||||||||
| 672136 | 08463001 | RELISTOR 12 mg/0,6 ml, SOLUCION INYECTABLE | RELISTOR 12 mg/0,6 ml, SOLUCION INYECTABLE, 1 vial de 0,6 ml | 12 mg | 45 | 1 | 34 | 1 vial de 0,6 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08463001/08463001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08463001/08463001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30213 | ZENTIVA SPAIN S.L. | 2009-01-09 | 1 | 1 | 1 | 2009-01-09 | 2011-03-28 | 1 | 2012-03-22 | 662079 | View Edit Delete | |||||||||||
| 672703 | 49313 | BLEOMICINA VIATRIS 15.000 UI (PH EUR) = 15 U (USP) POLVO PARA SOLUCION INYECTABLE | BLEOMICINA VIATRIS 15.000 UI (PH EUR) = 15 U (USP) POLVO PARA SOLUCION INYECTABLE, 1 vial | 15.000 UI | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/49313/49313_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/49313/49313_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44524 | VIATRIS PHARMACEUTICALS S.L. | 1971-04-01 | 1 | 1 | 1 | 1971-04-01 | 2011-03-29 | 1 | 2011-06-28 | 719542, 754564, 656759 | View Edit Delete | |||||||||||
| 675206 | 72862 | ROCURONIO TAMARANG 10 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG | ROCURONIO TAMARANG 10 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG , 10 viales de 5 ml | 10 mg/ml inyectable 5 ml | 45 | 10 | 34 | 10 viales de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72862/72862_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72862/72862_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 43981 | TAMARANG S.A. | 2011-05-16 | 1 | 1 | 1 | 2011-05-16 | 2011-05-16 | 1 | 2013-01-25 | View Edit Delete | ||||||||||||
| 674741 | 72725 | RIASTAP 1 G POLVO PARA SOLUCION INYECTABLE O PERFUSION | RIASTAP 1 G POLVO PARA SOLUCION INYECTABLE O PERFUSION, 1 vial | 1.000 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72725/72725_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72725/72725_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27753 | CSL BEHRING S.A. | 2011-03-08 | 1 | 1 | 1 | 2011-03-08 | 2011-03-08 | 1 | 2012-05-03 | View Edit Delete | ||||||||||||
| 672240 | 72571 | LEVACT 2,5 mg/ml POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | LEVACT 2,5 mg/ml POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 20 viales de 25 mg | 25 mg | 45 | 20 | 34 | 20 viales de 25 mg | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72571/72571_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72571/72571_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44015 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 2010-07-21 | 1 | 1 | 1 | 2010-07-21 | 2010-07-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 672241 | 72571 | LEVACT 2,5 mg/ml POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | LEVACT 2,5 mg/ml POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 5 viales de 100 mg | 100 mg | 45 | 5 | 34 | 5 viales de 100 mg | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72571/72571_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72571/72571_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44015 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 2010-07-21 | 1 | 1 | 1 | 2010-07-21 | 2010-07-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 672501 | 61490 | ULTIVA 5 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION | ULTIVA 5 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION , 5 viales | 5 mg | 45 | 5 | 34 | 5 viales | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61490/61490_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61490/61490_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 13382 | ASPEN PHARMACARE ESPANA S.L. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 0 | 2012-01-02 | Lista I | View Edit Delete | |||||||||||
| 672519 | 61489 | ULTIVA 2 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION | ULTIVA 2 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION , 5 viales | 2 mg | 45 | 5 | 34 | 5 viales | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61489/61489_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61489/61489_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 13382 | ASPEN PHARMACARE ESPANA S.L. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 0 | 2012-01-02 | Lista I | View Edit Delete |
Page 267 of 1036, showing 20 records out of 20704 total, starting on record 5321, ending on 5340